Skip to main content
. Author manuscript; available in PMC: 2020 Sep 24.
Published in final edited form as: Circulation. 2019 Aug 5;140(13):1070–1080. doi: 10.1161/CIRCULATIONAHA.119.040162

Fig.2.

Fig.2

In cardiomyocytes derived from induced pluripotent stem cells from 3 different male lines (A,B,C), acute (D,E,F) and chronic (G,H,I) exposure to enzalutamide prolonged action potential duration (J,K,L). **p<0.01 vs. control (n=5-7 each)